Abstract
Background Adjusting the basal insulin dose based on fasting plasma glucose (FPG) levels can facilitate better glycemic control. We examined whether FPG monitoring was associated with the optimal HbA1c target of <7.0 %, maintaining a low hypoglycemic rate, through comparison between FPG monitoring and six other monitoring methods.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
